Prescriber's Letter

PL Voices: Treatment of Gonorrhea
Chart: <a href="/Content/Segments/PRL/2011/Apr/Sexually-Transmitted-Diseases-Treatment-Guidelines-3191">Summary Sexually Transmitted Disease Guidelines (CDC, 2015)
Other: <a href="/Content/Segments/PRL/2015/Aug/Legal-Status-of-Expedited-Partner-Therapy-EPT-8705">Legal Status of Expedited Partner Therapy (EPT)
Patient Education: <a href="/Content/Segments/PRL/2015/Aug/For-Sex-Partners-of-Persons-with-Gonorrhea-8707">For Sex Partners of Persons with Gonorrhea
Patient Education: <a href="/Content/Segments/PRL/2015/Aug/For-Sex-Partners-of-Persons-with-Chlamydia-8706">For Sex Partners of Persons with Chlamydia

July 2018 Issue

You'll see renewed focus on using DUAL antibiotic therapy for gonorrhea....

Andexxa (an-DEK-sah, inactivated recombinant factor Xa) will be a new, IV direct oral anticoagulant (DOAC) reversal agent....

Buzz about CV benefits with SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) will spark curiosity about COMBINING them....

New data and talk of OTC label changes will reignite debate about whether NSAIDs reduce the CV protective effect of aspirin....